Cardiovascular Diseases Burden in COVID-19

“Given the potentially life-threating risks of heparin administration and limited data on it benefits, a personalized approach is needed for the use of heparin in COVID-19 patients. Cost and benefits of heparin administration needs to be carefully considered for each case before its use in COVID-19 patients”

https://authors.elsevier.com/c/1dsqe2dHVQ1KEW